# FDA recall D-1486-2019

> **Pfizer Inc.** · Class II · drug recall initiated 2019-07-09.

## Product

Milrinone Lactate Injection 200 mcg (0.2 mg)/mL* in 5% Dextrose Injection 40 mg/200 mL, 200 mL bag, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-2776-02, Barcode (01)00304092776028.

## Reason for recall

Lack of Assurance of Sterility: Bags have the potential to leak.

## Distribution

United States, PR, and Guam

## Key facts

- **Recall number:** D-1486-2019
- **Recalling firm:** Pfizer Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-07-09
- **Report date:** 2019-07-24
- **Termination date:** 2021-10-27

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New York, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1486-2019

## Citation

> AI Analytics. FDA recall D-1486-2019. Retrieved 2026-06-16 from https://api.ai-analytics.org/recall/D-1486-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*